MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)
CUSIP: 558868105
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,766,960
- Total 13F shares
- 2,046,899
- Share change
- +518,072
- Total reported value
- $33,282,527
- Price per share
- $16.26
- Number of holders
- 39
- Value change
- +$8,857,871
- Number of buys
- 30
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 558868105:
Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
1.9%
|
435,000
|
$6,699,000 | — | 31 Mar 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.8%
|
400,000
|
$6,160,000 | — | 31 Mar 2017 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.99%
|
225,000
|
$3,465,000 | — | 31 Mar 2017 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.56%
|
128,000
|
$1,971,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.39%
|
88,871
|
$1,368,000 | — | 31 Mar 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
57,875
|
$891,000 | — | 31 Mar 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.25%
|
57,762
|
$890,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
31,571
|
$486,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
25,821
|
$397,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
20,836
|
$321,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
19,935
|
$306,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
12,385
|
$191,000 | — | 31 Mar 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
11,724
|
$181,000 | — | 31 Mar 2017 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0.02%
|
5,150
|
$79,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
2,907
|
$45,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
2,172
|
$33,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,860
|
$29,000 | — | 31 Mar 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
600
|
$9,000 | — | 31 Mar 2017 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
547
|
$8,000 | — | 31 Mar 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
533
|
$8,000 | — | 31 Mar 2017 | |
| Evercore Wealth Management, LLC |
13F
|
Company |
0%
|
354
|
$5,000 | — | 31 Mar 2017 | |
| Creative Planning |
13F
|
Company |
0%
|
170
|
$3,000 | — | 31 Mar 2017 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
171
|
$2,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
128
|
$2,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
57
|
$1,000 | — | 31 Mar 2017 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
42
|
$1,000 | — | 31 Mar 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
42
|
$1,000 | — | 31 Mar 2017 | |
| Glen Eagle Advisors, LLC |
13F
|
Company |
0%
|
14
|
$216 | — | 31 Mar 2017 |
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q2 2017
As of 30 Jun 2017,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,046,899 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, ARMISTICE CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BAKER BROS. ADVISORS LP, NORTHERN TRUST CORP, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
25
Q2 2017 holders
39
Holder diff
14
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.